Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
12/2003
12/03/2003CN1129608C Method and apparatus for preparing acellular red blood cell substitute
12/02/2003US6656472 Multi oligosaccharide glycoconjugate bacterial meningitis vaccines
12/02/2003CA2161804C Purification of plasma proteins
12/02/2003CA2085308C Dibasic endoprotease fused to endoplasmic reticulum retention signal and use thereof
11/2003
11/27/2003WO2003097669A2 Method for purifying denatured proteins having a desired disulfide bond configuration
11/27/2003WO2003097667A1 Methods for measuring kinase activity and phosphatase activity
11/27/2003WO2003096985A2 3d structure of the tsg101 uev domain
11/27/2003WO2003080793A3 Treating solution containing aluminium ion for staining protein and staining method using the same
11/27/2003WO2003046150A3 Glycoprotein remodeling using endoglycanases
11/27/2003WO2003042249A3 Peptide purification by means of metal ion affinity chromatography
11/27/2003WO2003021274A3 Method for separating macromolecules having been chemically modified in a reversible manner
11/27/2003WO2003014144A3 Molecule
11/27/2003WO2002103008A3 Templated molecules and methods for using such molecules
11/27/2003WO2002081490A3 Computer-directed assembly of a polynucleotide encoding a target polypeptide
11/27/2003WO2002059603A3 Microdevices containing photorecognizable coding patterns and methods of using and producing the same thereof
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003WO2001058926A3 Protein mapping
11/27/2003US20030220472 Treatment of hematopoietic cell deficiencies, stimulating the production of hematopoietic cells, recombinant DNA sequence encodes or vector expression of the muteins; side effect reduction
11/27/2003US20030220470 Methods for the purification of stable radioiodine conjugates
11/27/2003US20030220234 A cyclosporine A derivative with isotopic or chemical substitution in the amino acid position selected from the group consisting of 1,3, and 9 or combination
11/27/2003US20030220233 Radiolabeled annexins
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/27/2003US20030219886 Directed evolution of novel binding proteins
11/27/2003US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2003US20030219854 Methods for producing modified anti-infective peptides
11/27/2003US20030219838 Polypeptide analyses using stable isotope labeling
11/27/2003US20030219830 Preparing polysaccharide conjugated glycoproteins for use as drug delivery tools in human therapeutics
11/27/2003US20030219758 Comprises nucleotide sequences for diagnosis, prevention and treatment of metastasis, autoimmune and nervous system disorders
11/27/2003US20030219722 Comprises preparation of novel binding prolypeptides via mutagenesis, expression, chromatographic selection and amplification; drug screening
11/27/2003US20030219486 Crosslinking agent reacts with reactive pendant groups existing on the keratin molecules to produce biocompatible heterogenous proteinaceous networks crosslinked with the heterogenous crosslinker
11/27/2003US20030219452 HIV envelope V3-CCR5 binding site immunogen
11/27/2003CA2483688A1 Methods for measuring kinase activity and phosphatase activity
11/26/2003EP1365028A1 Method for expression of PDGF or IGF proteins in yeast
11/26/2003EP1364208A2 Conjugates of defined stoichiometry
11/26/2003EP1363954A2 Polymer precursors of radiolabeled compounds, and methods of making and using the same
11/26/2003EP1363944A2 High-affinity antagonists of elr-cxc chemokines
11/26/2003EP1363934A1 Template-fixed peptidomimetics with antimicrobial activity
11/26/2003EP0822861B1 Remotely programmable matrices with memories and uses thereof
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1457884A Double virus inactivating/removing method for venous injection human immune globulin
11/26/2003CN1128811C Process for directly enriching nerve growth factor from raw venin
11/26/2003CN1128810C Polypeptide structure of shark liver of preventing and curing hepatitis and its purifying process
11/26/2003CN1128808C Cassia protein extracting process
11/25/2003US6653281 Ring modified cyclic peptide analogs
11/25/2003US6653103 For inhibiting export of nucleic acids from nucleus to cytoplasm of a cell
11/25/2003US6653098 Transforming cell with an expression vector comprising an isolated polynucleotide; solubilizing the inclusion bodies; refolding and purifying; urea, dithiothreitol and cysteine; angiogenesis inhibitors; anticarcinogenic agents
11/25/2003US6652885 Complexing drug with diketopiperazine; washing; separation of impurities
11/25/2003US6652808 Electric field assisted self-assembly of functionalized programmable nucleic acids, modified structures and other selective affinity or binding moieties
11/25/2003CA2105014C Imidazolidine derivatives
11/25/2003CA2100860C A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins
11/25/2003CA2086888C Whooping cough vaccine
11/20/2003WO2003095619A2 Protein complex purification
11/20/2003WO2003095473A2 Peptides and methods for cell death regulation
11/20/2003WO2003094961A1 Improved polysaccharide and glycoconjugate vaccines_____________
11/20/2003WO2003094959A1 Improved polysaccharide and glycoconjugate vaccines
11/20/2003WO2003053534A3 Device and method useable for integrated sequential separation and enrichment of proteins
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003035891A3 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor
11/20/2003WO2003016506A3 Secreted proteins
11/20/2003WO2002064734A3 Identification of target-specific folding sites in peptides and proteins
11/20/2003WO2002034915A3 Preferred segments of neural thread protein and methods of using the same
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216289 Treating leukemia or a solid tumor
11/20/2003US20030215949 Dehydroascorbate reductase ("DHAR") genes and their uses
11/20/2003US20030215917 Compositions and methods for quantification of extent of replication of Hepatitis C viral genome in an in vitro tissue culture system, in particular, replicon assay for identifying drug substances in high throughput screening format
11/20/2003US20030215912 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
11/20/2003US20030215911 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215910 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215897 Purifying target proteins using post-synaptic density 95, discs-large and zonular occludens (PDZ1) domain and a no receptor potential A (NorpA) sequence soluble matrix
11/20/2003US20030215822 Comprises nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological and developmental disorder
11/20/2003US20030215788 Of given amino acid sequence; ethylcarbamoyl; useful for detecting antibodies or antigens associated with retroviruses
11/20/2003US20030215542 Reduction of cystine containing polypeptides such as gliadins, glutenins, albumin or globulins, using thioredoxin or transferase enzymes; deactivation of neurotoxins
11/20/2003US20030215437 Polypeptide compositions and methods
11/20/2003CA2484279A1 Improved polysaccharide and glycoconjugate vaccines
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003EP1362595A1 Stable fibrinogen solution
11/19/2003EP0921855B1 Isolation of immunoglobulins
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1456664A Reorganized human glycogen phosphorylase isoenzyme BB and preparation thereof by methanal yeast and use thereof
11/19/2003CN1456662A Barm expressing system of plasminogen and purifying process
11/19/2003CN1456574A Preparing method for extracting polypeptide antibiotics from silkworm
11/19/2003CN1456572A Preparation of 2DE protein of corn solid pnase
11/19/2003CN1128157C Conjugate of lidamycin with active fragment of monoclonal antibody
11/19/2003CN1128156C Method for extracting immune globulin A from milk
11/19/2003CN1128155C Colored mistletoe herb goycoprotein extraction and its medicine composite and preparation
11/18/2003US6649736 Methods for carbon-centered radical mediated heavy hydrogen labeling of compounds
11/18/2003US6649735 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
11/18/2003US6649419 Recovering analyte from solution by using magnetic beads having a polymeric coating with hydrophobic groups which have binding affinity; can be used to purify, immobilize and assay antibodies
11/18/2003US6649370 Isolated polynucleotide which induces a immune response when administered to a mammal; expression vectors; vaccines
11/18/2003CA2223433C Ob protein compositions and methods
11/18/2003CA2045208C Inhibition of coloration of human serum albumin
11/13/2003WO2003093474A1 Psp94 binding protein and psp94 diagnostic assays
11/13/2003WO2003093346A1 Multifunctional polyethylene glycol derivatives: preparation and use
11/13/2003WO2003093302A2 Process for the synthesis of peptides amides by side-chain attachement to a solid phase
11/13/2003WO2003093301A2 Process for the synthesis of peptides
11/13/2003WO2003092848A2 Separation process and dyes for use therewith
11/13/2003WO2003092623A2 Calicheamicin derivative-carrier conjugates
11/13/2003WO2003040391A3 Method for producing and identifying soluble protein domains
11/13/2003WO2003035673A9 Supercritical fluids processing: preparation of protein microparticles and their stabilisation
1 ... 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 ... 518